Skip to content
10-Q

Quarterly Report

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD

0001400482-17-000052

← back to feed
Filed
May 10, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Apr 30, 2017 37.94M sh
Shares Diluted Q1 2017 · Mar 31, 2017 37.84M sh
Shares Diluted Q1 2017 · Mar 31, 2016 36.89M sh
Capex Q1 2017 · Mar 31, 2017 $38K
Capex Q1 2017 · Mar 31, 2016 $2K
Operating Cash Flow Q1 2017 · Mar 31, 2017 −$8.07M
Operating Cash Flow Q1 2017 · Mar 31, 2016 −$6.65M
Short Term Investments Q1 2017 · Mar 31, 2017 $102.17M
Short Term Investments Q1 2017 · Dec 31, 2016 $113.37M
Cash And Equivalents Q1 2017 · Mar 31, 2017 $12.24M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $8.95M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $7.72M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $5.09M
Stockholders Equity Q1 2017 · Mar 31, 2017 $134.2M
Stockholders Equity Q1 2017 · Dec 31, 2016 $141.82M
Current Liabilities Q1 2017 · Mar 31, 2017 $3.35M
Current Liabilities Q1 2017 · Dec 31, 2016 $4.61M
Current Assets Q1 2017 · Mar 31, 2017 $118.74M
Current Assets Q1 2017 · Dec 31, 2016 $127.32M
Total Assets Q1 2017 · Mar 31, 2017 $138.59M
Total Assets Q1 2017 · Dec 31, 2016 $147.38M
Eps Diluted Q1 2017 · Mar 31, 2017 −$0.23
Eps Diluted Q1 2017 · Mar 31, 2016 −$0.34
Eps Basic Q1 2017 · Mar 31, 2017 −$0.23
Eps Basic Q1 2017 · Mar 31, 2016 −$0.34
Sga Expense Q1 2017 · Mar 31, 2017 $4.14M
Sga Expense Q1 2017 · Mar 31, 2016 $7.78M
Rd Expense Q1 2017 · Mar 31, 2017 $4.88M
Rd Expense Q1 2017 · Mar 31, 2016 $8.92M
Net Income Q1 2017 · Mar 31, 2017 −$8.65M
Net Income Q1 2017 · Mar 31, 2016 −$12.59M
Operating Income Q1 2017 · Mar 31, 2017 −$9.02M
Operating Income Q1 2017 · Mar 31, 2016 −$12.94M
Revenue Q1 2017 · Mar 31, 2017 $0
Revenue Q1 2017 · Mar 31, 2016 $3.76M